Resultado da Busca
28 de nov. de 2023 · The calculations based on a total of 15 studies showed that a strategy of thrombophilia testing followed by indefinite anticoagulant treatment for patients with thrombophilia and stopping anticoagulant treatment for patients without thrombophilia would lead to 3 per 1000 fewer major bleeds in patients at low risk of bleeding (ranging ...
- Middeldorp, Saskia
21 de set. de 2017 · Summary of Recommendations Regarding Testing for Thrombophilia. The controversy surrounding testing stems from the demonstrated lack of effect of thrombophilia status on VTE outcomes,...
- Jean M Connors
- 2017
22 de ago. de 2023 · Hypercoagulability or thrombophilia is the increased tendency of blood to thrombose. A normal and healthy response to bleeding for maintaining hemostasis involves the formation of a stable clot, and the process is called coagulation.
- 2023/08/22
1 de jan. de 2007 · This article reviews the clinical manifestations of thrombophilia and addresses common questions on laboratory assessment and management: what are the potential indications for thrombophilia testing, who should be tested, what tests should be requested, when should testing be performed, and how should the test results affect primary ...
- John A. Heit
- 2007
29 de mai. de 2022 · In patients with stroke, an abnormal full blood count should prompt consideration for testing with an MPN panel and for PNH (Grade 2C). The presence of a PFO in patients with a stroke is not an indication for thrombophilia testing (Grade 2C).
3 de dez. de 2015 · Our study shows that those patients with PMH or FH of VTE were more likely to have thrombophilia studies. There is no consensus opinion as to whether to perform thrombophilia screenings in acute care settings.
2 de out. de 2020 · For patients with uncomplicated deep vein thrombosis (DVT), the American Society of Hematology (ASH) guideline panel suggests offering home treatment over hospital treatment (conditional recommendation based on low certainty in the evidence of effects ⨁⨁ ).
